Precision BioSciences is a biotechnology business based in the US. Precision BioSciences shares (DTIL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.75 – an increase of 12.52% over the previous week. Precision BioSciences employs 108 staff and has a trailing 12-month revenue of around $68.7 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $5.75 |
|---|---|
| 52-week range | $3.61 - $13.44 |
| 50-day moving average | $5.08 |
| 200-day moving average | $7.08 |
| Wall St. target price | $29.40 |
| PE ratio | 5.11 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $1.00 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.75 from 2025-05-02
| 1 week (2025-04-25) | 7.88% |
|---|---|
| 1 month (2025-04-04) | 24.73% |
| 3 months (2025-02-05) | 16.40% |
| 6 months (2024-11-05) | -32.03% |
| 1 year (2024-05-03) | -45.34% |
|---|---|
| 2 years (2023-05-04) | -76.77% |
| 3 years (2022-05-04) | 66.3 |
| 5 years (2020-05-05) | 212.4 |
Valuing Precision BioSciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Precision BioSciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Precision BioSciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Precision BioSciences shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $68.7 million |
|---|---|
| Gross profit TTM | $68.7 million |
| Return on assets TTM | -11.04% |
| Return on equity TTM | 19.05% |
| Profit margin | 10.43% |
| Book value | $6.88 |
| Market Capitalization | $58 million |
TTM: trailing 12 months
We're not expecting Precision BioSciences to pay a dividend over the next 12 months.
Precision BioSciences's shares were split on a 1:30 basis on 13 February 2024 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Precision BioSciences shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Precision BioSciences shares which in turn could have impacted Precision BioSciences's share price.
Over the last 12 months, Precision BioSciences's shares have ranged in value from as little as $3.61 up to $13.436. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precision BioSciences's is 1.584. This would suggest that Precision BioSciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Precision BioSciences, Inc. , a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. It offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. The company also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m. 3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Fidelity is best for its extensive tools and resources, while Robinhood is a popular choice for its simple, easy-to-use platform.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .